Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

Figure 3

Survival of the luminal B/HER2+ IHC surrogate classification and its ER/PR/HER2 component subtypes for stage 2.